Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 78.50
-1.50 (-1.88%)
Jan 28, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 393.96 million as of January 28, 2026. Its market cap has decreased by -8.36% in one year.
Market Cap
393.96M
Enterprise Value
370.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.50
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 393.96M, an increase of 242.46%. That is a compound annual growth rate of 33.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 393.96M | 3.09% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 621.93M |
| Captor Therapeutics Spolka Akcyjna | 447.83M |
| BIOTON | 343.46M |
| Synthaverse | 283.08M |
| Molecure | 146.28M |
| Mabion | 132.37M |
| Poltreg | 119.85M |
| NanoGroup | 88.64M |